- £107.70m
- £154.00m
- £168.40m
- 38
- 61
- 85
- 68
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 124 | 107 | 145 | 138 | 168 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 101 | 97.7 | 123 | 113 | 162 |
Operating Profit | 22.6 | 9.4 | 21.8 | 25.2 | 6.2 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 19 | 6.7 | 20.1 | 22.2 | 0 |
Provision for Income Taxes | |||||
Net Income After Taxes | 15.9 | 7.7 | 19.4 | 17.3 | 5.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 16 | 7.6 | 19.4 | 17.5 | 4.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 16 | 7.6 | 19.4 | 17.5 | 4.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.457 | 0.403 | 0.436 | 0.381 | 0.243 |
Dividends per Share |